Work

Abstract 4833: Activation of ERBB2 signaling causes resistance to the EGFR-directed therapeutics antibody cetuximab

Year: 2012

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2012-4833

Authors: Kimio Yonesaka, Isamu Okamoto, Satoh Taroh, Kreshnik Zejnullahu, Kazuto Nishio, Masahiro Fukuoka, Pasi A. Janne, Kazuhiko Nakagawa

Institutions: Kindai University Hospital, Kindai University, The University of Osaka, Dana-Farber Cancer Institute, Izumi City General Hospital

Language: English

Topic: HER2/EGFR in Cancer Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2001821686

Cites:

Cited by: 4

Related to: 10